Topics :: AIDS treatment

1 thru 10 of 26 Stories

Seattle Experts Call for End to AIDS-related Fungal Infections

By EDGE | Mar 12
Currently about 1,500,000 people die of AIDS and its complications each year. Many die of fungal infections; how many is not clear because of a lack of access to excellent diagnostic tests.

Gov. Cuomo Announces 'End of AIDS' Taskforce

By Winnie McCroy | Oct 21
On October 14, Governor Andrew M. Cuomo announced the creation of the End of AIDS Task Force to implement his bold plan to end new HIV infections in the Empire State by 2020.

AIDS Scientist Pleads Not Guilty to Faking Study

By David Pitt | Jul 11
A former Iowa State University scientist pleaded not guilty Tuesday to charges alleging that he falsified research for an AIDS vaccine to secure millions of dollars in federal funding.

Basic Healthcare Eludes HIV+ Prisoners

By EDGE | Dec 20
When it comes to HIV, many U.S. prison systems are still living in the Dark Ages.

’The Battle of amfAR’ Debuts on HBO

By Winnie McCroy | Dec 10
HBO Documentary Films will present "The Battle of amfAR," the story of the founding of the American Foundation for AIDS Research, the nation’s first AIDS research foundation, by Elizabeth Taylor and research scientist Dr. Mathilde Krim.

amfAR Mourns Loss of Nelson Mandela

Dec 8
amfAR leadership bids a fond farewell to former South African president Nelson Mandela, who passed away on December 5.

Making the Impossible Possible: Yoga and HIV

By EDGE | Dec 4
The same benefits as for other people are magnified for HIV-positive practitioners of yoga, which is why it has become so popular.

Winning One for the Team

By Cyd Zeigler Jr. | Nov 29
People with HIV can play any team sport with just a brief pre-game check-in at the doctor’s office. The rewards are physical exercise and an instant social circle.

ASOs Praise Senate’s Reauthorization of PEPFAR

By Winnie McCroy | Nov 26
AIDS Service Organizations are thrilled by the House of Representatives’ passage of the PEPFAR Stewardship and Oversight Act.

FDA Approves GlaxoSmithKline AIDS Drug Tivicay

By Winnie McCroy | Aug 22
The FDA has approved GlaxoSmithKline Plc’s once-daily drug Tivicay to treat the most common strain of HIV.

1 thru 10 of 26 Stories